Diagnosis and treatment of orphan disease — homocystinuria and megaloblastic anemia, type cblG
暂无分享,去创建一个
[1] J. Thevenon,et al. The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders , 2021, Molecular genetics and metabolism reports.
[2] I. Rudan,et al. Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence , 2018, Journal of global health.
[3] M. Baumgartner,et al. Newborn screening for homocystinurias: Recent recommendations versus current practice , 2018, Journal of inherited metabolic disease.
[4] E. Nikolaeva,et al. Clinical and Molecular Characteristics of Russian Patients with Homocystinuria due to Cystathionine Beta-Synthase Deficiency , 2018 .
[5] W. Craigen,et al. Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. , 2017, Molecular genetics and metabolism.
[6] M. Baumgartner,et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency , 2016, Journal of Inherited Metabolic Disease.
[7] I. T. de Almeida,et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency , 2016, Journal of Inherited Metabolic Disease.
[8] M. Thall,et al. Neuropsychiatric Illness in a Patient with Cobalamin G Disease, an Inherited Disorder of Vitamin B12 Metabolism , 2004, Harvard review of psychiatry.